September 4th
February 27th
January 28th
November 12th
October 29th
July 12th
March 21st
March 16th
December 19th
October 26th
October 25th
October 24th
October 19th
Viacor, Inc. Announces First Patient Treated in PTOLEMY-2 Study - Earthtimes
Author : Viacor, Inc. WILMINGTON, Mass. , Nov. 14 -- Viacor, Inc., a privately held company focused on the development of percutaneous therapies for cardiac valve repair, announced today that the first patient in the PTOLEMY-2 ( P ercutaneous T ...
Navigating the holiday gauntlet - Southside Times
It?s not flashy, it?s not exciting, but if anyone ever makes a list of the greatest ideas in the history of American culture, early family holidays must be among the best. My extended family is doing this on Sunday. We?re getting together for ...
Cardiac Dimensions® Inc. Announces New Vice Presidentof Research ... - Genetic Engineering News
Cardiac Dimensions ® Inc., is pleased to announce that Mr. Robert Conta has joined the company as Vice President of Research and Development (R&D). Mr. Conta comes to Cardiac Dimensions from Spiration Inc., a medical device company that manufactures ...
A Statist View of the Constitution - Nolanchart.com
On an article I wrote recently, someone asked the question "How do statists view the Constitution?" I think this is an excellent question to tackle. First, however, a disclaimer. Read at the risk of being offended. If you don't like the views I state ...
Viacor initiates treatment in heart failure study - Pharmaceutical Business Review
Ptolemy-2 is an international, multi-center clinical trial designed to assess the safety and efficacy of the Viacor Percutaneous Transvenous Mitral Annuloplasty (PTMA) system in heart failure patients. The first Ptolemy-2 patient was treated by ...
Do you prefer to listen to your regurgitation gossip? Check out Podzy Podcast Directory > Regurgitation.
Looking for regurgitation related products, then look no further. Try our new Regurgitation Shop.